<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">World J Gastroenterol</journal-id>
<journal-id journal-id-type="iso-abbrev">World J. Gastroenterol</journal-id>
<journal-id journal-id-type="publisher-id">WJG</journal-id>
<journal-title-group>
<journal-title>World Journal of Gastroenterology : WJG</journal-title>
</journal-title-group>
<issn pub-type="ppub">1007-9327</issn>
<issn pub-type="epub">2219-2840</issn>
<publisher>
<publisher-name>Baishideng Publishing Group Inc</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26457021</article-id>
<article-id pub-id-type="pmc">4588083</article-id>
<article-id pub-id-type="other">jWJG.v21.i37.pg10609</article-id>
<article-id pub-id-type="doi">10.3748/wjg.v21.i37.10609</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Brain-gut-microbiota axis in Parkinson's disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mulak</surname>
<given-names>Agata</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonaz</surname>
<given-names>Bruno</given-names>
</name>
</contrib>
<aff>Agata Mulak, Department of Gastroenterology and Hepatology, Wroclaw Medical University, 50-556 Wroclaw, Poland</aff>
<aff>Bruno Bonaz, Grenoble Institut des Neurosciences (GIN), INSERM U836, 38043 Grenoble, France</aff>
<aff>Bruno Bonaz, Clinique Universitaire d’Hépato-Gastroentérologie, CHU de Grenoble, 38043 Grenoble, France</aff>
</contrib-group>
<author-notes>
<fn>
<p>Author contributions: Mulak A designed and wrote the paper; Bonaz B designed, wrote and reviewed the paper.</p>
<p>Correspondence to: Agata Mulak, MD, PhD, Department of Gastroenterology and Hepatology, Wroclaw Medical University, Borowska 213, 50-556 Wroclaw, Poland. <email>agata.mulak@wp.pl</email></p>
<p>Telephone: +48-71-7332120 Fax: +48-71-7332129</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>7</day>
<month>10</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="epub">
<day>7</day>
<month>10</month>
<year>2015</year>
</pub-date>
<volume>21</volume>
<issue>37</issue>
<fpage>10609</fpage>
<lpage>10620</lpage>
<history>
<date date-type="received">
<day>2</day>
<month>3</month>
<year>2015</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>5</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>8</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.</copyright-statement>
<copyright-year>2015</copyright-year>
</permissions>
<abstract>
<p>Parkinson’s disease (PD) is characterized by alpha-synucleinopathy that affects all levels of the brain-gut axis including the central, autonomic, and enteric nervous systems. Recently, it has been recognized that the brain-gut axis interactions are significantly modulated by the gut microbiota <italic>via</italic> immunological, neuroendocrine, and direct neural mechanisms. Dysregulation of the brain-gut-microbiota axis in PD may be associated with gastrointestinal manifestations frequently preceding motor symptoms, as well as with the pathogenesis of PD itself, supporting the hypothesis that the pathological process is spread from the gut to the brain. Excessive stimulation of the innate immune system resulting from gut dysbiosis and/or small intestinal bacterial overgrowth and increased intestinal permeability may induce systemic inflammation, while activation of enteric neurons and enteric glial cells may contribute to the initiation of alpha-synuclein misfolding. Additionally, the adaptive immune system may be disturbed by bacterial proteins cross-reacting with human antigens. A better understanding of the brain-gut-microbiota axis interactions should bring a new insight in the pathophysiology of PD and permit an earlier diagnosis with a focus on peripheral biomarkers within the enteric nervous system. Novel therapeutic options aimed at modifying the gut microbiota composition and enhancing the intestinal epithelial barrier integrity in PD patients could influence the initial step of the following cascade of neurodegeneration in PD.</p>
</abstract>
<kwd-group>
<kwd>Brain-gut-microbiota axis</kwd>
<kwd>Enteric nervous system</kwd>
<kwd>Gastrointestinal dysfunction</kwd>
<kwd>Gut microbiota</kwd>
<kwd>Parkinson’s disease</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>